Abstract
Many attempts have been made to create partially obstructed coronary arteries in animals that can then be studied and manipulated to produce controlled decreases in coronary flow so that controlled increments of ischemia would be induced. Such a model would require the production of a fixed amount of stenosis, which would allow for essentially normal coronary flow with the animal at rest, but would cause ischemia and sudden death under many of the conditions known to increase the likelihood of sudden death in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Folts JD. Experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance. Cardiovasc Rev Rep 1982; 3: 370–382.
Folts JD. An in vivo model of experimental arterial stenosis, intimal damage and periodic thrombosis. Circulation 1991; Suppl 4:IV3–14.
Folts JD, Gallagher K, Rowe GG. Hemodynamic effects of controlled degrees of coronary artery stenosis in short-term and long-term studies in dogs. J Thorac Cardiovasc Surg 1977; 73: 722–727.
Folts JD. A model of experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance: an update. Cardiovasc Rev Rep 1990; 11: 10–26.
Ashton JH, Ogletree ML, Michel intramuscularly, Golino P, McNatt JM, Taylor AL, et al. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Circulation 1987; 76: 952–959.
Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, et al. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. Circulation 1993; 88: 1205–1214.
Maalej N, Holden JE, Folts JD. Effect of shear stress on acute platelet thrombus formation in canine stenosed carotid arteries: An in vivo quantitative study. Journal of Thrombosis and Thrombolysis 1998; 5: 231–238.
Folts JD, Gallagher K, Rowe GG. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 1982; 65: 248–255.
Bush LR, Shebuski RJ. In vivo models of arterial thrombosis and thrombolysis. FASEB. J 1990; 4: 3087–3098.
Gering SA, Folts JD. Exacerbation of acute platelet thrombus formation in stenosed dog coronary arteries with smoke from a non-tobacco-burning cigarette. J Lab Clin Med 1990; 116: 728–736.
Bolli R, Ware A, Brandon TA, Weilbaecher DG, Mace ML. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist. J Am Coll Cardiol 1984; 3: 1417–1426.
Bush LR, Campbell WB, Buja M, Tilton G, Willerson JT. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation 1984; 69: 1161–1170.
O’Rourke ST, Folts JD, Albrecht RM. Inhibition of canine platelet aggregation by barbiturates. J Lab Clin Med 1986; 108: 206–212.
Bertha BG, Folts JD, Nugent M, Rusy BF. Halothane, but not isoflurane or enflurane, protects against spontaneous and epinephrine-exacerbated acute thrombus formation in stenosed dog coronary arteries. Anesthesiology 1989; 71: 96–102.
Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed coronary arteries and their inhibition with aspirin. Clin Res 1974; 22: 595A.
Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365–370.
Rao GH, Escolar G, White JG. Epinephrine reverses the inhibitory influences of aspirin on platelet-vessel wall interactions. Thromb Res 1986; 44: 65–74.
Folts JD. Drugs for the prevention of coronary thrombosis: from an animal model to clinical trials. Cardiovasc Drugs Ther 1995; 9: 31–43.
Maalej N, Folts JD. Effect of shear stress on acute platelet thrombus formation in canine stenosed carotid arteries: An in vitro quantitative study.
Sherry S. Aspirin and antiplatelet drugs: the clinical approach. Cardiovasc Rev Rep 1984; 5: 1208–1219.
Ikeda H, Koga Y, Kuwano K, Nakayama H, Ueno T, Yoshida N, et al. Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans. J Am Coll Cardiol 1993; 21: 1008–1017.
Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 1989; 80: 198–205.
Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995; 91: 1182–1188.
Osman HE, Maalej N, Shanmuganayagam D. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys. J Nutr 1998; 128: 2307–2312.
Slane PR, Folts JD. Platelet inhibition in stenosed canine coronary arteries by quercetin and rutin, polyphenolic flavonoids found in red wine. Clin Res 1994; 42: 162A.
Folts JD. Commercial mixture of flavonoids, ProVex CV, inhibits in vivo thrombosis and ex vivo platelet aggregation in dogs and humans. J Invest Med 1998; 46: 199A.
Hill DS, Smith SR, Folts JD. The rabbit as a model for carotid artery stenosis, and periodic acute thrombosis. Fed Proc 1987; 46: 421.
Folts JD, Mosher DF. Transient declines in stenosed monkey carotid artery blood flow due to acute platelet thrombus formation. Thromb Haemostasis 1983; 50: 20.
Coller BS, Folts JD, Smith SR, Scudder LE, Jordan R. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation 1989; 80: 1766–1774.
Schumacher WA, Goldenberg HJ, Harris DN, Ogletree ML. Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomologus monkey. J Pharmacol Exp Ther 1987; 243: 460–466.
Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56–63.
Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, et al. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA 1991; 88:10, 624–10, 628.
Eidt J, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury. J Clin Invest 1989; 84: 517–527.
Folts JD, Gering SA, Laibly SW, Bertha BG, Bonebrake FC, Keller JW. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis. Adv Exp Med Biol 1990; 273: 339–58: 339–358.
Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982; 65: 465–470.
Eichhorn EJ, Grayburn PA, Willard JE, Anderson HV, Bedotto JB, Carry M, et al. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol 1991; 17: 43–52.
Folts JD. Cigarette smoking and thrombus formation. Am Heart J 1988; 116: 1657–1658.
Anderson HV, Kirkeeide RL, Krishnaswami A, Weigelt LA, Revana M, Weisman HF, et al. Cyclic flow variations after coronary angiogplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol 1994; 23: 1031–1037.
Yao SK, McNatt J, Cui K, Anderson HV, Maffrand JP, Buja LM, et al. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates. Circulation 1993; 88: 2888–2893.
Folts JD. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin. Int J Cardiol 1997; 62: S111–S117.
Folts JD, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation 1991; 83: 2122–2127.
Rovin JD, Stamler JS, Loscalzo J, Folts JD. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries. J Cardiovasc Pharmacol 1993; 22: 626–631.
Folts JD, Rowe GG. Dipyridamole does not inhibit thrombus formation in stenosed canine coronary arteries nor does it augment the inhibitory effect of low dose aspirin. Journal of Vascular Medicine and Biology 1989; 1: 255–261.
Schafer AI. Antiplatelet therapy. Am J Med 1996; 101: 199–209X.
Fitzgerald GA. Dipyridamole. N Engl J Med 1987; 316: 1247–1257.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Folts, J.D. (2001). Folts Cyclic Flow Animal Model for Studying in Vivo Platelet Activity and Platelet Interactions with Damaged Arterial Walls. In: Simon, D.I., Rogers, C. (eds) Vascular Disease and Injury. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-003-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-003-2_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-169-1
Online ISBN: 978-1-59259-003-2
eBook Packages: Springer Book Archive